Cell Culture & Bioprocessing:

Getting cell therapy products onto the market as quickly as possible still remains a key driver in the improve of recombinant therapeutic proteins. Any such advance in bioprocessing is of particular interest to the industry if it considerably shortens the development timeline or improves the end product. In the monoclonal antibody (MAb) area, platform procedures have allowed companies to regulate on particular mammalian cell lines, transfection approaches, process conditions and also downstream processing to shorten the development timeline.

  • Nano methods to target cancer cells
  • Nano micro fluids in cell therapy
  • Nano materials and nano engineering
  • Nano vaccines
  • Pros & cons of molecular manufacturing

Related Conference of Cell Culture & Bioprocessing:

September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-20, 2020

24th European Biotechnology Congress (EBC_2020)

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Cell Culture & Bioprocessing: Conference Speakers

Recommended Sessions

Related Journals

Are you interested in